Estimates of the reproduction numbers of Spanish influenza using morbidity data

International Journal of Epidemiology

Volumn 36, Issue 4, 2007, Pages 881-889

  Vynnycky, Emilia ^a   Trindall, Amy ^a,c   Mangtani, Punam ^b  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Infectious Disease Epidemiology Unit   (United Kingdom)

^c Public Health Directorate   (United Kingdom)

Author keywords

Modelling; Reproduction numbers; Spanish influenza

Indexed keywords

EPIDEMIC; ESTIMATION METHOD; HISTORICAL RECORD; INFLUENZA; MODELING; MORBIDITY;

ARTICLE; COMMUNITY LIVING; EPIDEMIC; EUROPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFLUENZA VIRUS; MORBIDITY; PANDEMIC; PRIORITY JOURNAL; SPANISH INFLUENZA; SUPERINFECTION; URBAN POPULATION; VIRUS REPLICATION; VIRUS TRANSMISSION; WESTERN HEMISPHERE;

DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; EUROPE; HUMANS; INFLUENZA, HUMAN; MODELS, STATISTICAL; MORBIDITY; RISK ASSESSMENT; UNITED STATES;

ORTHOMYXOVIRIDAE;

EID: 34548598462     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym071     Document Type: Article

References (30)

1. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005;352:1839-42.
2. Ministry of health. Report on the Pandemic of Influenza. London: His Majesty's Stationery Office, 1920, Report no. 4.
3. Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature 2004;432:904-6.
4. Spicer CC, Lawrence CJ. Epidemic influenza in Greater London. J Hyg (Lond) 1984;93:105-12.
5. Chowell G, Ammon C, Hengartner N, Hyman J. Estimation of the reproductive number of the Spanish flu epidemic in Geneva, Switzerland. Vaccine 2006;24:6747-50.
6. Stanley L. Influenza at San Quentin prison, California. Public Health Rep 1919;34:996-1008.
7. Frost W, Sydenstricker B. Influenza in Maryland. Preliminary statistics of certain localities. Public Health Rep 1919;34:491-504.
8. Dietz K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res 1993;2:23-41.
9. Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Med 2005;2:621-27.
10. Becker N. Analysis of Infectious Disease Data. London: Chapman and Hall, 1989.
11. Hope-Simpson RE. The period of communicability of certain epidemic diseases. Lancet 1948;13:755-60.
12. Fine PE. The interval between successive cases of an infectious disease. Am J Epidemiol 2003;158:1039-47.
13. Anderson RM, Medley GF, May RM, Johnson AM. A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol 1986;3 229-63.
14. Lipsitch M, Cohen T, Cooper B et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003;300 1966-70.
15. Murphy BR, Baron S, Chalhub EG, Uhlendorf CP, Chanock RM. Temperature-sensitive mutants of influenza virus. IV. Induction of interferon in the nasopharynx by wild-type and a temperature-sensitive recombinant virus. J Infect Dis 1973;128:488-93.
16. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966;122:800-4.
17. Couch RB, Douglas RG Jr, Fedson DS, Kasel JA. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis 1971;124:473-80.
18. Calfee DP, Peng AW, Cass LM, Lobo M, Hayden FG. Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. Antimicrob Agents Chemother 1999;43:1616-20.
19. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 1996;275:295-99.
20. Hayden FG, Treanor JJ, Fritz RS et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282(13):1240-46.
21. Hayden F, Fritz R, Lobo M, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. J Clin Invest 1998;101:643-49.
22. Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000;283:1016-24.
23. Reeve P, Gerendas B, Moritz A et al. Studies in man with cold-recombinant influenza virus (H1N1) live vaccines. J Med Virol 1980;6:75-83.
24. Ferguson NM, Cummings DA, Cauchemez S et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005;437:209-14.
25. Olson DR, Simonsen L, Edelson PJ, Morse SS. Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci USA 2005;102:11059-63.
26. Stuart-Harris C. Epidemiology of influenza in man. Br Med Bull 1979;35:3-8.
27. Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. Am J Epidemiol 1985; 121:811-22.
28. Jordan WS Jr, Denny FW Jr, Badger GF et al. A study of illness in a group of Cleveland families. XVII. The occurrence of Asian influenza. Am J Hyg 1958;68:190-212.
29. Davis LE, Caldwell GG, Lynch RE, Bailey RE, Chin TD. Hong Kong influenza: The epidemiologic features of a high school family study analyzed and compared with a similar study during the 1957 Asian influenza epidemic. Am J Epidemiol 1970;92:240-47.
30. Woodall J, Rowson KEK, McDonald J. Age and Asian influenza, 1957. Br Med J 1958;5108:1316-18.